Himadri Speciality Chemical Recommends Final Dividend of ₹0.80 per Share for FY26
Himadri Speciality Chemical's Board approved FY26 audited financial results and recommended a final dividend of ₹0.80 per share. They also re-appointed auditors and independent directors. A new wholly-owned subsidiary in China was approved.
The dividend recommendation and the strategic decision to incorporate a foreign subsidiary are material events for the company.
The recommendation of a final dividend and approval of financial results are positive indicators for the company.
Himadri Speciality Chemical Limited announced the outcome of its Board Meeting held on April 23, 2026. The Board has approved the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. Additionally, the Board has recommended a final dividend of ₹0.80 per equity share of ₹1 each (80% of face value) for the financial year 2025-26, subject to shareholder approval.
The Board also re-appointed M/s Ernst & Young, LLP as the Internal Auditor for the financial year 2026-27 and appointed Mr. Sambhu Banerjee as the Cost Auditor for the same period. Furthermore, the Board approved the re-appointment of Mr. Girish Paman Vanvari and Mr. Gopal Ajay Malpani as Independent Directors for a second term of five years, commencing June 22, 2026, and August 13, 2026, respectively, subject to shareholder approval.
In a significant strategic move, the Board has approved the incorporation of a wholly-owned subsidiary in Guangzhou, China. The Board meeting commenced at 12:00 p.m. IST and concluded at 4:00 p.m. IST on April 23, 2026.
What to do with a filing like this
Himadri Speciality Chemical Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Himadri Speciality Chemical Limited. Read the original for the full detail.